×
About 8,615 results

ALLMedicine™ Hyperparathyroidism Center

Research & Reviews  3,012 results

Underdiagnosis of primary hyperparathyroidism in patients with osteoarthritis undergoin...
https://doi.org/10.1016/j.surg.2021.09.035
Surgery Park SY, Scotting O et. al.

Dec 1st, 2021 - Primary hyperparathyroidism (HPT) is commonly underdiagnosed and undertreated. Joint pain is a nonspecific symptom associated with osteoarthritis or primary HPT. We hypothesize that patients treated for osteoarthritis are underdiagnosed with prima...

Risk of Fracture Among Older Adults With Primary Hyperparathyroidism Receiving Parathyr...
https://doi.org/10.1001/jamainternmed.2021.6437
JAMA Internal Medicine; Seib CD, Meng T et. al.

Nov 30th, 2021 - Primary hyperparathyroidism (PHPT) contributes to the development and progression of osteoporosis in older adults. The effectiveness of parathyroidectomy for reducing fracture risk in older adults is unknown. To compare the incidence of clinical f...

Parathyroidectomy in Elderly Individuals With Primary Hyperparathyroidism: To Operate o...
https://doi.org/10.1001/jamainternmed.2021.6816
JAMA Internal Medicine; Habib AR, Katz MH

Nov 30th, 2021 - Parathyroidectomy in Elderly Individuals With Primary Hyperparathyroidism: To Operate or Not to Operate.|2021|Habib AR,Katz MH,|

Real-World Assessment: Clinical Effectiveness and Safety of Extended-Release Calcifediol.
https://doi.org/10.1159/000518545
American Journal of Nephrology; Fadda G, Germain MJ et. al.

Nov 25th, 2021 - The safety and efficacy of extended-release calcifediol (ERC) as a treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency (VDI) has been demonstrated in prospective r...

see more →

Guidelines  6 results

ACR Appropriateness Criteria® Parathyroid Adenoma.
https://doi.org/10.1016/j.jacr.2021.08.013
Journal of the American College of Radiology : JACR; , Zander D et. al.

Nov 20th, 2021 - Hyperparathyroidism is defined as excessive parathyroid hormone production. The diagnosis is made through biochemical testing, in which imaging has no role. However, imaging is appropriate for preoperative parathyroid gland localization with the i...

New scenarios in secondary hyperparathyroidism: etelcalcetide. Position paper of workin...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7118036
Journal of Nephrology; Bellasi A, Cozzolino M et. al.

Dec 20th, 2019 - Bone mineral abnormalities (defined as Chronic Kidney Disease Mineral Bone Disorder; CKD-MBD) are prevalent and associated with a substantial risk burden and poor prognosis in CKD population. Several lines of evidence support the notion that a lar...

National Osteoporosis Society vitamin D guideline summary.
https://doi.org/10.1093/ageing/afu093
Age and Ageing; Aspray TJ, Bowring C et. al.

Jul 31st, 2014 - The National Osteoporosis Society (NOS) published its document, Vitamin D and Bone Health: A Practical Clinical Guideline for Patient Management, in 2013 as a practical clinical guideline on the management of vitamin D deficiency in adult patients...

AME position statement: primary hyperparathyroidism in clinical practice.
https://www.ncbi.nlm.nih.gov/pubmed/22824948
Journal of Endocrinological Investigation; Zini M, Attanasio R et. al.

Jul 25th, 2012 - AME position statement: primary hyperparathyroidism in clinical practice.|2012|Zini M,Attanasio R,Cesareo R,Emmolo I,Frasoldati A,|therapeutic use,etiology,therapeutic use,therapeutic use,complications,diagnosis,drug therapy,surgery,etiology,blood,

European League Against Rheumatism recommendations for calcium pyrophosphate deposition...
https://doi.org/10.1136/ard.2010.139105
Annals of the Rheumatic Diseases; Zhang W, Doherty M et. al.

Jan 11th, 2011 - To agree terminology and to develop recommendations for the diagnosis of calcium pyrophosphate deposition (CPPD). The European League Against Rheumatism (EULAR) CPPD Task Force, comprising 15 experts from 10 countries, agreed the terms and recomme...

see more →

Drugs  138 results see all →

Clinicaltrials.gov  117 results

Gait and Balance Parameters Before and After Parathyroidectomy in Patients With Primary Hyperparathyroidism
https://clinicaltrials.gov/ct2/show/NCT03713671

Oct 21st, 2021 - Parathyroid hormone, released from the parathyroid gland, plays an important role in keeping the ionized calcium in between the reference values in body. Precise control of ionized calcium is particularly necessary to ensure the optimal function o...

Studies of Inherited Diseases of Metabolism
https://clinicaltrials.gov/ct2/show/NCT00001345

Oct 18th, 2021 - Familial multiple endocrine neoplasia type 1 (MEN1), familial hypocalciuric (or familial benign) hypercalcemia (FHH), hyperparathyroidism - jaw tumor syndrome (HPT-JT), other causes of familial isolated hyperparathyroidism (FIHP), and pseudohypopa...

The Crosstalk Between Calcium-sensing Receptor Signaling and Endocannabinoid System in Primary Hyperparathyroidism
https://clinicaltrials.gov/ct2/show/NCT03831620

Oct 12th, 2021 - Despite the strong association of hyperparathyroidism with arachidonic acid related lipid signals, little research has been performed over the years. A better understanding of the link between arachidonic acid remodeling, prostaglandin and endocan...

Vitamin k1 and Its Relation to Vascular Calcification in Hemodialysis Patients
https://clinicaltrials.gov/ct2/show/NCT05060809

Oct 5th, 2021 - Vascular calcification (VC) represents one of the major complications associated with progressive renal impairment. In addition, VC has been regarded as one of the major predictors of cardiovascular risk, the most common cause of mortality in chro...

Total Parathyroidectomy With Autotransplantation Versus Total Parathyroidectomy Alone for Secondary Hyperparathyroidism
https://clinicaltrials.gov/ct2/show/NCT04922892

Sep 27th, 2021 - The trial was performed as a nonconfirmatory randomized controlled pilot trial with 200 patients on long-term dialysis with otherwise uncontrollable SHPT to generate data on the rate of recurrent disease within a 5-year follow-up period after TPTX...

see more →

News  166 results

Dr. Sosa on Risk Factors for Thyroid Cancer
https://www.onclive.com/view/dr-sosa-on-risk-factors-for-thyroid-cancer

Oct 6th, 2021 - Julie Ann Sosa, MD, MA, FACS, FSSO, chair, Department of Surgery, Leon Goldman, MD Distinguished Professor of Surgery, professor, Department of Medicine, affiliated faculty, Philip R. Lee Institute for Health Policy Studies, University of Californ...

Neuroendocrine Tumors Clinical Practice Guidelines (NCCN, 2021)
https://www.medscape.com/viewarticle/959868

Sep 30th, 2021 - Updated clinical guidelines on the diagnosis and management of neuroendocrine and adrenal tumors were released in 2021 by the National Comprehensive Cancer Network (NCCN). The new version of the guidelines, published in the Journal of the National...

Hypercalcemia? When to Worry
https://www.medscape.com/viewarticle/955925

Aug 10th, 2021 - This transcript has been edited for clarity. Matthew F. Watto, MD: We are back. Paul, what are we talking about today? Paul N. Williams: MD: We're going to be discussing our podcast on hypercalcemia with the wildly enthusiastic and incredibly smar...

Fast Five Quiz: Chronic Kidney Disease (CKD) Hyperphosphatemia
https://reference.medscape.com/viewarticle/948765

Apr 26th, 2021 - Hyperphosphatemia or abnormally high serum phosphate levels, has been identified as a key factor associated with cardiovascular complications and increased mortality risk among patients with chronic kidney disease (CKD). Hyperphosphatemia is a lat...

Genetic Testing and Screening in Medullary Thyroid Cancer
https://www.onclive.com/view/genetic-testing-and-screening-in-medullary-thyroid-cancer

Apr 2nd, 2021 - For High-Definition, Click Nearly a quarter of patients with medullary thyroid cancer (MTC) have a hereditary version of the disease that is related to MEN 2A, MEN 2B, or a familial MTC syndrome. Each of these syndromes is associated with a uniq...

see more →

Patient Education  7 results see all →